1/11
Looks like no tags are added yet.
What are the two many stages?
Pre-clinical stage
Clinical stage
Pre-clinical stage
Vaccine development and design
In vitro testing (laboratory testing)
In vivo testing (animal testing)
Analysis and Evaluation
Vaccine development and design
Scientists identify the pathogen (virus or bacterium) that causes the disease.
They identify suitable antigens that could trigger an immune response.
A vaccine candidate is developed using an appropriate technology, such as mRNA, a proteinsubunitor a weakened/inactivated pathogen.
In vitro testing
The vaccine is tested on cells and tissues in the laboratory.
Scientists investigate whether it can stimulate an immune response.
They assess how cells respond to the vaccine and look for potential harmful effects.
In vivo testing
The vaccine is tested in suitable animals, such as mice or non-human primates,wherescientifically justified.
Scientists investigate whether the vaccine triggers an immune response.
They assess its safety, potential toxicity and ability to protect against infection
Analysis and Evaluation
Results from laboratory and animal testing are analysed.
Scientists assess the vaccine's safety, effectiveness and potential side effects.
If the results are promising, the vaccine may be approved by regulators to progress toPhase1 human clinical trials.
What happens after pre-clinical testing?
If the vaccine shows promising enough results, it moves forward to clinical trials for testing in people
What are the stages of clinical trials?
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1
Giving the vaccine to a small number of healthy people - around 20–100 volunteers
Tests whether the vaccine is safe for humans.
Identifies any immediate side effects.
Investigates the initial immune response.
Helps determine an appropriate dosage.
Main aim: To assess safety and identify potential side effects.
Phase 2
Involves a larger number of people to test whether the vaccine triggers an immune response
100 - 300 volunteers
includes trial participants who have characteristics (such as age and physical health) similar to the intended recipients for the vaccine
They can also include groups of people from diverse backgrounds to ensure representation across different populations
Investigates the correct dosage and vaccination schedule.
Monitors side effects and safety.
Measures the immune response, such as antibody production.
Main aim: To assess safety further and determine the best dose and schedule.
Phase 3
Involves thousands of volunteers, sometimes tens of thousands.
Often uses a randomised, controlled trial.
Participants may receive either the vaccine or a placebo/comparator.
Compares infection or disease rates between groups.
Monitors common and less common side effects.
Main aim: To establish whether the vaccine is effective and gather further safety information.